DRRX DURECT CORP Capital Structure Changes 8-K Filing 2023 - Equity Offerings On July 19, 2023, DURECT Corporation entered an agreement to sell 2,991,027 shares of its common stock and accompanying warrants, in a registered direct offering, to institutional healthcare investors. The aggregate gross proceeds from the offering were $15 million, excluding any potential proceeds from the exercise of the common warrants.Get access to all SEC 8-K filings of the DURECT CORP